Home › Atherosclerosis › Texas › McKinney
Atherosclerosis clinical trials in McKinney, TX
3 studies for Atherosclerosis are looking for participants at sites in and around McKinney (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
RecruitingPhase 2
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
RecruitingPhase 3
- Revival Research Institute, LLC, McKinney
- Texas Institute of Cardiology, PA, McKinney
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
RecruitingPhase 3
- Research Site, McKinney
About Atherosclerosis
Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.
More about Atherosclerosis on MedlinePlus
Atherosclerosis trials in other cities
- Boston, MA10 studies
- Houston, TX10 studies
- Washington, DC9 studies
- Orlando, FL8 studies
- Arlington, VA8 studies
- Hialeah, FL8 studies
- Durham, NC7 studies
- Memphis, TN7 studies
- Miami, FL7 studies
- Dallas, TX7 studies
- Las Vegas, NV7 studies
- Omaha, NE6 studies
Other studies in McKinney
- Heart Failure7 studies
- Type 2 Diabetes6 studies
- Asthma5 studies
- COPD5 studies
- Chronic Kidney Disease4 studies
- Cardiovascular Disease4 studies
- Obesity4 studies
- Interstitial Lung Diseases3 studies
- Graves Disease3 studies
- Atrial Fibrillation3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.